U.S. Launch and First Commercial Use of Abbott’s New EnSite™ Precision Cardiac Mapping System

« Back to Industry News


Abbott has announced the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, Sensor Enabled™ to map cardiac arrhythmias during ablation treatments.

Cardiac mapping provides an inside view of the heart so physicians can visualize and navigate cardiac anatomy to deliver more precise ablation therapy.

Built on a foundation of the St. Jude Medical™ cardiac mapping technology utilized in more than 2,000 electrophysiology labs around the world, the new EnSite Precision cardiac mapping system is the latest addition to the company’s electrophysiology portfolio. This next-generation technology is designed to provide automation, flexibility and precision in cardiac mapping during the treatment of patients with abnormal heart rhythms (cardiac arrhythmias). Its dual-technology platform provides highly detailed anatomical models and maps to enable more efficient treatment of a wide range of irregular heart rhythms — including complex arrhythmias, such as atrial fibrillation or ventricular tachycardia.

The EnSite Precision cardiac mapping system introduces new solutions, including the EnSite™ AutoMap Module, which enables the electrophysiologist to more quickly perform morphology matching that identifies the source of the irregular heartbeat. The EnSite AutoMap Module includes the new TurboMap feature, which allows the physician to build a map of the heart 10 times faster than current systems using recorded data.

The first commercial use of the system after U.S. FDA clearance occurred at the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City during ablation procedures conducted by electrophysiologist John Day, M.D.

Additional procedures supported by the new EnSite Precision cardiac mapping system have occurred in 12 states nationwide, supporting ablation procedures to treat complex arrhythmias.

Abbott says it expects its new cardiac mapping technology to quickly become a new standard for use in treating patients experiencing arrhythmias from multiple origins in the heart. In the coming weeks, physicians across the country will begin to use the EnSite Precision cardiac mapping system.

Click here to view the full related article.

« Back to Industry News